Q1’s Industry Insights round up all the latest regulatory news
Articles filtered by tag
Our latest Industry Update finishes the year focusing on COVID-19 & BREXIT
All the information you need on the BREXIT transition direct from our Regulatory Team
Find out about the MHRA Submissions Portal by talking to our team.
All the latest regulatory updates compiled for you by S-cubed.
Latest news from EMA regarding nitrosamines
Our latest Industry Update for Q2 covers the latest regulatory information around COVID-19 and much more.
Latest updates from EMA in response to the COVID-19 pandemic.
The deadline for Nitrosamine Risk Evaluation is looming. Are you ready?
Our first Industry Update of 2020 focuses on Clinical Trial Regulation, Brexit and the latest from FDA & EMA.
With just one month to go, have you completed your risk evaluations? Make sure you are ready!
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities